Who can use Opdualag(Nivolumab and Relatlimab)?

This section provides a concise description of OPDUALAG, a dual-immunotherapy agent.

Who can use Opdualag(Nivolumab and Relatlimab)?

OPDUALAG is a fixed-dose combination injection containing two distinct monoclonal antibodies: nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody. It is formulated as a sterile, preservative-free solution for intravenous use. This combination represents a novel mechanism of action that simultaneously targets two different immune checkpoints to enhance the anti-tumor immune response. The product is supplied in a single-dose vial and requires specific storage conditions to maintain stability.